Torfil 2.5/Torfil 10/Torfil 20 Adverse Reactions

Torfil 2.5: The most commonly reported adverse events associated with the use of tadalafil were headache, upper abdominal pain, and myalgia. These adverse events were mild to moderate, transient and decreased with continued dosing. Other common adverse events were gastroesophageal reflux disease, nausea, vomiting, arthralgia, and muscle spasm. The table as follows shows other adverse event that were minor, those with no plausible relation to drug use, and reports were too imprecise to be meaningful. (See Table 1.)

Click on icon to see table/diagram/image

Torfil 10/Torfil 20: The most commonly reported adverse events associated with the use of tadalafil were headache and dyspepsia. These adverse events were mild to moderate, transient and decreased with continued dosing. Other common adverse events were myalgia, back pain, flushing and nasal congestion. Uncommon adverse events reported were swelling of eyelids, sensations described as eye pain, conjunctival hyperaemia, dyspnea, and dizziness. In post-marketing surveillance, the following adverse events were reported. (See Table 2.)

Click on icon to see table/diagram/image